Gladius Capital Management LP Mckesson Corp Transaction History

Gladius Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Dec 18, 2023	BUY	$335.35 - $386.06 $584,515 - $672,902	1,743 New	1,743 $620,000
Q1 2023 May 09, 2023	BUY	$335.35 - $386.06 $28,169 - $32,429	84 Added 5.06%	1,743 $621,000
Q4 2022 Dec 18, 2023	BUY	$346.68 - $397.58 $575,142 - $659,585	1,659 New	1,659 $622,000
Q4 2022 Feb 02, 2023	SELL	$346.68 - $397.58 $124,111 - $142,333	-358 Reduced 17.75%	1,659 $623,000
Q3 2022 Nov 14, 2022	SELL	$321.25 - $373.84 $29,233 - $34,019	-91 Reduced 4.32%	2,017 $687,000
Q2 2022 Aug 10, 2022	SELL	$300.57 - $336.42 $127,141 - $142,305	-423 Reduced 16.71%	2,108 $689,000
Q1 2022 Apr 29, 2022	BUY	$244.61 - $310.48 $81,210 - $103,079	332 Added 15.1%	2,531 $775,000
Q4 2021 Feb 08, 2022	BUY	$198.21 - $248.9 $435,863 - $547,331	2,199 New	2,199 $547,000

1,713

112M

871K

900K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $75.6B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Gladius Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Gladius Capital Management LP with notifications on news.